Literature DB >> 20227846

Rapid diagnostic testing for seasonal influenza: an evidence-based review and comparison with unaided clinical diagnosis.

Jeffrey J Petrozzino1, Cynthia Smith, Mark J Atkinson.   

Abstract

BACKGROUND: Worldwide, seasonal influenza imposes a considerable health and economic burden. Clinical diagnosis of influenza-like illness (ILI) is complicated by non-specific symptomatology. Rapid flu tests (RFTs) impact treatment decisions and may improve patient care; yet, recommendations for RFT use are broad, and the performance of unaided clinical diagnosis relative to RFTs is unclear.
OBJECTIVES: To determine age-stratified, overall sensitivities and specificities of the widely studied RFT, QuickVue® (Quidel Corporation, San Diego, CA), and clinical diagnosis of ILI by meta-analysis and to seek factors associated with poorer clinical diagnostic discrimination.
METHODS: A systematic literature review was conducted using article selection criteria identifying studies indexed in PubMed/MEDLINE, the Cochrane Library, and other pertinent sources of studies reporting sensitivity, specificity, and effects of RFTs and clinical diagnosis on decision-making for patients with ILI.
RESULTS: QuickVue's® diagnostic specificity exceeds that of unaided clinical diagnosis by 29-31%. False-positive results occur approximately 8.2 times more frequently by unaided clinical diagnosis than by the RFT alone. These findings were unaffected by seasonal variations in disease prevalence. RFTs reduce diagnostic testing, antibiotic use, and emergency department utilization while increasing antiviral prescription rates. No systematic relationship between the broadness of clinical diagnostic criteria for influenza and diagnostic performance was observed across studies included in this review.
CONCLUSIONS: Use of RFTs improves seasonal influenza diagnostic specificity above that based on unaided clinical diagnosis irrespective of the broadness of clinical diagnostic criteria, and affects clinical decision-making. These results provide an improved framework upon which to diagnose influenza, design future RFT studies, and modify existing recommendations for improved ILI patient management.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20227846     DOI: 10.1016/j.jemermed.2009.11.031

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  12 in total

1.  Duration of viral shedding and factors associated with prolonged shedding among inpatients with influenza treated with oseltamivir: a prospective cohort study.

Authors:  J Khoury; M Szwarcwort; Z Kra-Oz; M Saffuri; K Seh; T Yahalomi; E Braun; Z S Azzam; M Paul; A Neuberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-11-15       Impact factor: 3.267

2.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.

Authors:  Tamar F Barlam; Sara E Cosgrove; Lilian M Abbo; Conan MacDougall; Audrey N Schuetz; Edward J Septimus; Arjun Srinivasan; Timothy H Dellit; Yngve T Falck-Ytter; Neil O Fishman; Cindy W Hamilton; Timothy C Jenkins; Pamela A Lipsett; Preeti N Malani; Larissa S May; Gregory J Moran; Melinda M Neuhauser; Jason G Newland; Christopher A Ohl; Matthew H Samore; Susan K Seo; Kavita K Trivedi
Journal:  Clin Infect Dis       Date:  2016-04-13       Impact factor: 9.079

3.  Can newly developed, rapid immunochromatographic antigen detection tests be reliably used for the laboratory diagnosis of influenza virus infections?

Authors:  James J Dunn; Christine C Ginocchio
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

Review 4.  Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.

Authors:  Sarah Kg Tonkin-Crine; Pui San Tan; Oliver van Hecke; Kay Wang; Nia W Roberts; Amanda McCullough; Malene Plejdrup Hansen; Christopher C Butler; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2017-09-07

Review 5.  Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: a Paradigm Shift to Molecular Tests.

Authors:  Marwan M Azar; Marie L Landry
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948

6.  Detection of influenza A and B with the Alere ™ i Influenza A & B: a novel isothermal nucleic acid amplification assay.

Authors:  Briony Hazelton; Timothy Gray; Jennifer Ho; V Mala Ratnamohan; Dominic E Dwyer; Jen Kok
Journal:  Influenza Other Respir Viruses       Date:  2015-02-27       Impact factor: 4.380

7.  Performance of the Cobas(®) Influenza A/B Assay for Rapid Pcr-Based Detection of Influenza Compared to Prodesse ProFlu+ and Viral Culture.

Authors:  L Chen; Y Tian; S Chen; O Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-12-04

8.  Impact of implementing respiratory point-of-care testing in a regional haemato-oncology unit.

Authors:  E J Goldstein; R Dhillon; C McCullough; T Inkster; R Soutar; R N Gunson
Journal:  J Hosp Infect       Date:  2020-06-20       Impact factor: 3.926

9.  Performance and ease of use of a molecular point-of-care test for influenza A/B and RSV in patients presenting to primary care.

Authors:  Jan Y Verbakel; Veerle Matheeussen; Katherine Loens; Mandy Kuijstermans; Herman Goossens; Margareta Ieven; Christopher C Butler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-03-14       Impact factor: 3.267

10.  The Clinical Utility of Point-of-Care Tests for Influenza in Ambulatory Care: A Systematic Review and Meta-analysis.

Authors:  Joseph Jonathan Lee; Jan Y Verbakel; Clare Rosemary Goyder; Thanusha Ananthakumar; Pui San Tan; Phillip James Turner; Gail Hayward; Ann Van den Bruel
Journal:  Clin Infect Dis       Date:  2019-06-18       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.